Patent · US Active

Method for expression of small antiviral RNA molecules within a cell

US7732207B2 · kind B2 · utility

11Cited by
15References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 21, 2007
Grant dateJun 8, 2010
Priority date
Expiry dateAug 29, 2027

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In one aspect, the invention provides methods and compositions for the expression of small RNA molecules within a cell using a retroviral vector (FIG. 1A). The methods can be used to express double stranded RNA complexes. Small interfering RNA (siRNA) can be expressed using the methods of the invention within a cell, that interfere with a viral life cycle by down regulating either the viral genome, a viral genome transcript, or a host cell that. In another aspect the invention provides methods for treating patients having suffering from infection, particularly infection with HIV. In a further aspect, the invention provides methods for producing siRNA encoding lentivirus where the siRNA activity may interfere with the lentiviral life cycle.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.